06

2018

-

12

The union's re-election conference and the first meeting of the fourth employee representative assembly was successfully held.

Source:


The union's re-election conference and the first meeting of the fourth employee representative conference was successfully held.
On the afternoon of November 23, 2018, the company's union committee re-election conference and the first meeting of the fourth employee representative conference was successfully held. According to the "Trade Union Law" and other relevant regulations, this election adopted a differential, secret ballot method. The union elected the fourth union committee, financial review committee, and women's committee. The representative conference reviewed and approved the proposal for "Chongqing Pharmaceutical (Group) Co., Ltd. to transfer its 43.11% equity in the company at the Chongqing Property Joint Exchange" and the proposal for "the company to relocate to the Liangjiang Industrial Park in Jiangbei District."
At the meeting, company leaders Xiao Jinmai, Liu Liping, Qin Yongmei, and Fu Xiaotai delivered important speeches, expressing high hopes for the new union leadership team and outlining a grand development blueprint for the medical engineering institute's future. Representatives at the meeting also spoke freely, offering suggestions and fully expressing their opinions.
The establishment of the new union committee marks a new chapter in the company's union work. The new union leadership team and the new employee representatives will live up to their mission, actively perform their duties, continuously explore new ideas for union work, and actively create a new situation for union work, uniting and leading all employees to make new and greater contributions to the construction and development of the medical engineering institute.
1
 
2
Appendix: List of the fourth union organization:
Union Committee: Zhang Daolin (Union Chairman), Yang Fan, Tian Maojun, Liu Qiwan, Li Jia
Union Financial Review Committee: Tian Maojun (Director), He Ling, Hu Xiangang
Union Women's Committee: Li Jia (Director), Hu Jia, Xiong Juan

Key words:

The digital transformation of the pharmaceutical industry is accelerating. How can pharmaceutical companies strategize to achieve sales growth?

In the future digital transformation of the pharmaceutical industry, how should pharmaceutical companies position themselves

2021-04-13

The current status of the development of the pharmaceutical industry in China in 2020.

2019 was an important year for the transformation and key upgrade of the pharmaceutical industry in our country.

2021-04-13

Progress has been made in the research of nano-medicines for pancreatic cancer.

Pancreatic cancer has a high mortality rate, and its fundamental reason for being difficult to treat lies in the fact

2021-04-13

Building a communication platform for government and enterprises to discuss new opportunities for high-quality development in the pharmaceutical industry.

Nanfang Daily News - On April 9, the fifth Cloud Cheng Tian Yu Food and Drug Review and Certification

2021-04-13